BeiGene launches $650m ADS follow-on
Chinese biopharmaceutical company BeiGene is looking to raise about $650m from a follow-on offering of American Depository Shares (ADSs), according to a filing with the US regulator.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: